<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00763295</url>
  </required_header>
  <id_info>
    <org_study_id>08-015</org_study_id>
    <nct_id>NCT00763295</nct_id>
  </id_info>
  <brief_title>Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?</brief_title>
  <official_title>Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      HIV infection highly increases the risk of progression of latent tuberculosis (TB) to active
      disease that therapy is recommended for all PPD-positive, HIV-infected patients, regardless
      of age. Sensitivity of the PPD testing is, however, dependent on a normal T cell function.

      Therefore, an accurate and reliable method for detection of latent tuberculosis in patients
      with HIV is urgently needed.

      This prospective study will examine the utility of interferon-gamma (IFN-γ) based assay,
      T-SPOT.TB,for detection of TB in HIV-infected individuals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">53</enrollment>
  <condition>Latent Tuberculosis</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>HIV infection</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>T-Spot.TB test</intervention_name>
    <description>diagnostic test</description>
    <arm_group_label>HIV infection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with HIV confirmed by standard methods
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  adult individuals with confirmed HIV infection

        Exclusion Criteria:

          -  Patients who are on INH treatment

          -  Patients who have a positive PPD test within 1 year of study enrollment

          -  Individuals with blistering or ulcerating skin disorder

          -  Pregnant women

          -  Patients who were given blood transfusion within 6 weeks prior to enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Staten Island University Hospital</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2008</study_first_submitted>
  <study_first_submitted_qc>September 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <last_update_submitted>October 25, 2012</last_update_submitted>
  <last_update_submitted_qc>October 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2012</last_update_posted>
  <responsible_party>
    <name_title>Jordan Glaser, MD</name_title>
    <organization>Staten Island University Hospital</organization>
  </responsible_party>
  <keyword>latent tuberculosis</keyword>
  <keyword>HIV</keyword>
  <keyword>IFN-γ based assay</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Latent Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

